EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior

Suvekshya Aryal iD, Shelby L Bachman iD, Kate Lyden, Ieuan Clay

JCO Clinical Cancer Informatics · 2023

DOI: 10.1200/cci.23.00055 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JCO Clinical Cancer Informatics, 2023. Verfasst von Suvekshya Aryal und 3 weiteren Autor:innen. Beteiligte Einrichtung: VivoSense Inc, Newport Coast, CA. Hauptthemen laut MEDLINE: Cachexia, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE The burden of cancer cachexia on patients' health-related quality of life, specifically their physical functioning, is well documented, but clinical trials thus far have failed to show meaningful improvement in physical functioning. The purpose of this review is to summarize existing methods of assessing physical function in cancer cachexia, outline a path forward for measuring what is meaningful to patients using digital measures derived from digital health technologies (DHTs), and discuss the current landscape of digital measures from the clinical and regulatory standpoint. DESIGN For this narrative review, peer-reviewed articles were searched on PubMed, clinical trials records were searched on clinicaltrials.gov, and records of digital measures submitted for regulatory qualification were searched on the US Food and Drug Administration's Drug Development Tool Qualification Program database. RESULTS There are gaps in assessing aspects of physical function that matter to patients. Existing assessment methods such as patient-reported outcomes and objective performance outcomes have limitations, including their episodic nature and burden to patients. DHTs such as wearable sensors can capture real-world physical behavior continuously, passively, and remotely, and may provide a more comprehensive picture of patients' everyday functioning. Recent regulatory submissions showcase potential clinical implementation of digital measures in various therapeutic areas. CONCLUSION Digital measures of real-world physical behavior present an opportunity to detect and demonstrate improvements in physical functioning in cancer cachexia, but evidence-based development is critical. For their use in clinical and regulatory decision making, studies demonstrating meaningfulness to patients as well as feasibility and validation are necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsHumansQuality of LifeClinical Trials as Topic

Autor:innen und Institutionen

  • VivoSense Inc, Newport Coast, CA.

ORCID-Profile: Suvekshya Aryal, Shelby L Bachman

Zitieren

APA

Aryal, S., Bachman, S. L., Lyden, K., & Clay, I. (2023). Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.23.00055

Vancouver

Aryal S, Bachman SL, Lyden K, Clay I. Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior. JCO Clinical Cancer Informatics. 2023. doi:10.1200/cci.23.00055

BibTeX
@article{Aryal2023,
  author = {Aryal, Suvekshya and Bachman, Shelby L and Lyden, Kate and Clay, Ieuan},
  title = {Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior},
  journal = {JCO Clinical Cancer Informatics},
  year = {2023},
  doi = {10.1200/cci.23.00055}
}
Kostenlos starten →